David L. Lucchino's Insider Trades & SAST Disclosures
David L. Lucchino's most recent trade in Korro Bio Inc. was a trade of 5,190 Stock Option (Right to Buy) done . Disclosure was reported to the exchange on June 11, 2024.
Add Superstar Alert
Share
Note
This is a custom search result for pattern David L. Lucchino.To see full superstar portfolios of large investors like Warren Buffet, Elon Musk and others, click here.
Advanced/Help
"Balanced Fund": Use this format with quotation marks to find the exact phrase. The output matches
"Balanced Fund"
but not "Balanced Growth Fund"
Balanced Fund: Use this format without quotation marks to search for all funds related to the term
"Balanced Fund" The results may include
"Balanced Income Fund", "Balanced Growth Fund" and any fund name containing "Balanced Fund".
Showing you 100 results sorted by most recent dates.
| Stock | Client Name | Client Category | Action | Reported to Exchange | Quantity | Post Transaction Holding | Traded % | Avg. Price | Value | Security Type |
|---|---|---|---|---|---|---|---|---|---|---|
| Korro Bio Inc. | David L. Lucchino | Director | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 11 Jun 2024 | 5,190 | 5,190 | - | - | Stock Option (Right to Buy) | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.50 per share. | 18 Aug 2023 | 3,057 | 633,744 (2%) | 0% | 0.5 | 1,529 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.60 per share. | 18 Aug 2023 | 2,865 | 636,801 (2%) | 0% | 0.6 | 1,719 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 16 Aug 2023 | 2,895 | 642,399 (2%) | 0% | 0.7 | 1,882 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 16 Aug 2023 | 2,733 | 639,666 (2%) | 0% | 0.6 | 1,722 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.63 per share. | 14 Aug 2023 | 2,881 | 647,923 (2%) | 0% | 0.6 | 1,815 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 14 Aug 2023 | 2,629 | 645,294 (2%) | 0% | 0.7 | 1,761 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.68 per share. | 10 Aug 2023 | 2,790 | 653,537 (2%) | 0% | 0.7 | 1,897 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 10 Aug 2023 | 2,733 | 650,804 (2%) | 0% | 0.7 | 1,831 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.69 per share. | 08 Aug 2023 | 2,810 | 659,125 (2%) | 0% | 0.7 | 1,939 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.67 per share. | 08 Aug 2023 | 2,798 | 656,327 (2%) | 0% | 0.7 | 1,875 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.68 per share. | 04 Aug 2023 | 2,857 | 661,935 (2%) | 0% | 0.7 | 1,943 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.69 per share. | 04 Aug 2023 | 2,550 | 664,792 (2%) | 0% | 0.7 | 1,760 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 02 Aug 2023 | 2,679 | 667,342 (2%) | 0% | 0.6 | 1,581 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.52 per share. | 02 Aug 2023 | 2,587 | 670,021 (2%) | 0% | 0.5 | 1,345 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.49 per share. | 31 Jul 2023 | 2,799 | 672,608 (2%) | 0% | 0.5 | 1,372 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.50 per share. | 31 Jul 2023 | 2,676 | 675,407 (2%) | 0% | 0.5 | 1,338 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.51 per share. | 27 Jul 2023 | 2,791 | 680,730 (2%) | 0% | 0.5 | 1,423 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.47 per share. | 27 Jul 2023 | 2,647 | 678,083 (2%) | 0% | 0.5 | 1,244 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.50 per share. | 25 Jul 2023 | 2,803 | 686,130 (2%) | 0% | 0.5 | 1,402 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.52 per share. | 25 Jul 2023 | 2,609 | 683,521 (2%) | 0% | 0.5 | 1,357 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.54 per share. | 21 Jul 2023 | 2,887 | 688,933 (2%) | 0% | 0.5 | 1,559 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.61 per share. | 21 Jul 2023 | 2,663 | 691,820 (2%) | 0% | 0.6 | 1,624 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.64 per share. | 19 Jul 2023 | 2,710 | 694,483 (2%) | 0% | 0.6 | 1,734 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.65 per share. | 19 Jul 2023 | 2,646 | 697,193 (2%) | 0% | 0.7 | 1,720 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.56 per share. | 17 Jul 2023 | 2,968 | 699,839 (2%) | 0% | 0.6 | 1,662 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.68 per share. | 17 Jul 2023 | 2,775 | 702,807 (2%) | 0% | 0.7 | 1,887 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.39 per share. | 13 Jul 2023 | 2,646 | 707,397 (2%) | 0% | 0.4 | 1,032 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.59 per share. | 13 Jul 2023 | 1,815 | 705,582 (2%) | 0% | 0.6 | 1,071 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.37 per share. | 11 Jul 2023 | 2,731 | 712,692 (2%) | 0% | 0.4 | 1,010 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.39 per share. | 11 Jul 2023 | 2,649 | 710,043 (2%) | 0% | 0.4 | 1,033 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.35 per share. | 07 Jul 2023 | 2,634 | 718,014 (2%) | 0% | 0.4 | 922 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.38 per share. | 07 Jul 2023 | 2,591 | 715,423 (2%) | 0% | 0.4 | 985 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 300,000 | 723,421 (2%) | 0% | - | Common Stock | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2023 | 300,000 | 0 | - | - | Restricted Stock Units | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2023 | 33,345 | 423,421 (1%) | 0% | 0 | Common Stock | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Gift of securities by or to the insider at price $ 0.00 per share. | 01 Feb 2023 | 13,345 | 456,766 (1%) | 0% | 0 | Common Stock | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 0.34 per share. | 01 Feb 2023 | 2,773 | 720,648 (2%) | 0% | 0.3 | 943 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 26 Jan 2023 | 280,000 | 280,000 | - | - | Restricted Stock Unit | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 714,413 | 714,413 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 714,413 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 242,500 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 242,500 | 242,500 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Aug 2022 | 200,000 | 200,000 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale or transfer of securities back to the company at price $ 0.00 per share. | 17 Aug 2022 | 200,000 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 17 Feb 2022 | 300,000 | 300,000 | - | - | Restricted Stock Unit | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 18 Jan 2022 | 6,905 | 470,111 (1%) | 0% | 0.6 | 4,212 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 18 Jan 2022 | 6,905 | 0 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Nov 2021 | 6,905 | 13,810 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 02 Nov 2021 | 6,905 | 456,301 (1%) | 0% | 0.6 | 4,212 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 05 Oct 2021 | 6,905 | 20,715 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 05 Oct 2021 | 6,905 | 449,396 (1%) | 0% | 0.6 | 4,212 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 03 Sep 2021 | 6,905 | 442,491 (1%) | 0% | 0.6 | 4,212 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Sep 2021 | 6,905 | 27,620 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Aug 2021 | 6,905 | 34,525 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 03 Aug 2021 | 6,905 | 435,586 (1%) | 0% | 0.6 | 4,212 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Jul 2021 | 6,905 | 41,430 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 01 Jul 2021 | 6,905 | 428,681 (1%) | 0% | 0.6 | 4,212 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 21 Jun 2021 | 113,690 | 421,776 (1%) | 0% | 0.6 | 69,351 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 21 Jun 2021 | 113,690 | 48,335 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Mar 2021 | 9,416 | 162,025 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 01 Mar 2021 | 9,416 | 317,502 (1%) | 0% | 0.6 | 5,744 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 51.76 per share. | 01 Mar 2021 | 4,202 | 308,278 (1%) | 0% | 51.8 | 217,492 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 01 Mar 2021 | 2,688 | 312,480 (1%) | 0% | 50.0 | 134,410 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 48.85 per share. | 01 Mar 2021 | 1,255 | 315,168 (1%) | 0% | 48.9 | 61,311 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 47.84 per share. | 01 Mar 2021 | 1,079 | 316,423 (1%) | 0% | 47.8 | 51,618 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 52.11 per share. | 01 Mar 2021 | 192 | 308,086 (1%) | 0% | 52.1 | 10,005 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 08 Feb 2021 | 16,554 | 171,441 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 08 Feb 2021 | 16,554 | 324,640 (1%) | 0% | 0.6 | 10,098 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 52.50 per share. | 08 Feb 2021 | 5,518 | 319,122 (1%) | 0% | 52.5 | 289,695 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 57.50 per share. | 08 Feb 2021 | 5,518 | 308,086 (1%) | 0% | 57.5 | 317,285 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 55.00 per share. | 08 Feb 2021 | 5,518 | 313,604 (1%) | 0% | 55 | 303,490 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 03 Feb 2021 | 11,036 | 319,122 (1%) | 0% | 0.6 | 6,732 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 03 Feb 2021 | 11,036 | 187,995 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 47.50 per share. | 03 Feb 2021 | 5,518 | 313,604 (1%) | 0% | 47.5 | 262,105 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 50.00 per share. | 03 Feb 2021 | 5,518 | 308,086 (1%) | 0% | 50 | 275,900 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 02 Feb 2021 | 5,518 | 313,604 (1%) | 0% | 0.6 | 3,366 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 02 Feb 2021 | 5,518 | 199,031 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 45.76 per share. | 02 Feb 2021 | 3,800 | 309,804 (1%) | 0% | 45.8 | 173,882 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 46.84 per share. | 02 Feb 2021 | 1,709 | 308,095 (1%) | 0% | 46.8 | 80,051 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 47.33 per share. | 02 Feb 2021 | 9 | 308,086 (1%) | 0% | 47.3 | 426 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 01 Feb 2021 | 33,102 | 204,549 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 01 Feb 2021 | 33,102 | 341,188 (1%) | 0% | 0.6 | 20,192 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 42.85 per share. | 01 Feb 2021 | 18,600 | 319,688 (1%) | 0% | 42.9 | 797,099 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 43.71 per share. | 01 Feb 2021 | 8,900 | 310,788 (1%) | 0% | 43.7 | 389,056 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 41.29 per share. | 01 Feb 2021 | 2,900 | 338,288 (1%) | 0% | 41.3 | 119,755 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 44.58 per share. | 01 Feb 2021 | 2,702 | 308,086 (1%) | 0% | 44.6 | 120,459 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 27 Jan 2021 | 9,196 | 317,282 (1%) | 0% | 0.6 | 5,610 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 27 Jan 2021 | 9,196 | 237,651 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 42.50 per share. | 27 Jan 2021 | 9,196 | 308,086 (1%) | 0% | 42.5 | 390,830 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Grant, award, or other acquisition of securities at price $ 0.00 per share. | 15 Jan 2021 | 200,000 | 200,000 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 06 Jan 2021 | 27,586 | 335,672 (1%) | 0% | 0.6 | 16,827 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 06 Jan 2021 | 27,586 | 246,847 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 37.45 per share. | 06 Jan 2021 | 10,707 | 324,065 (1%) | 0% | 37.4 | 400,977 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 40.00 per share. | 06 Jan 2021 | 9,496 | 308,086 (1%) | 0% | 40.0 | 379,810 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 38.26 per share. | 06 Jan 2021 | 4,164 | 319,901 (1%) | 0% | 38.3 | 159,315 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 39.37 per share. | 06 Jan 2021 | 2,319 | 317,582 (1%) | 0% | 39.4 | 91,299 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 36.13 per share. | 06 Jan 2021 | 900 | 334,772 (1%) | 0% | 36.1 | 32,517 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Sale of securities on an exchange or to another person at price $ 32.89 per share. | 04 Jan 2021 | 22,241 | 319,949 (1%) | 0% | 32.9 | 731,462 | Common Stock |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.00 per share. | 04 Jan 2021 | 14,477 | 274,433 | - | - | Stock Option | |
| Frequency Therapeutics Inc | David L. Lucchino | Director, President and CEO | Exercise or conversion of derivative security received from the company (such as an option) at price $ 0.61 per share. | 04 Jan 2021 | 14,477 | 342,190 (1%) | 0% | 0.6 | 8,831 | Common Stock |
*All Values are in $ Million
Client Category: Promoter/ KMP/ Director / Immediate Relatives / Employee / etc
Security Type: Share/ Warrants / Convertible Debentures
Security Type: Share/ Warrants / Convertible Debentures
Data as reported to USA Exchanges